-
Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum.
Weber DG, Johnen G, Taeger D, Weber A, Gross IM, Pesch B, Kraus T, Brüning T, Gube M.
Biomark Insights. 2010 Jan 28; 5:1-8. Epub 2010 Jan 28.
[Biomark Insights. 2010]
-
Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study.
Xanthopoulos A, Bauer TT, Blum TG, Kollmeier J, Schönfeld N, Serke M.
J Occup Med Toxicol. 2008 Dec 18; 3:34. Epub 2008 Dec 18.
[J Occup Med Toxicol. 2008]
-
Clinical consequences of asbestos-related diffuse pleural thickening: A review.
Miles SE, Sandrini A, Johnson AR, Yates DH.
J Occup Med Toxicol. 2008 Sep 8; 3:20. Epub 2008 Sep 8.
[J Occup Med Toxicol. 2008]
- » See all...